Cafepharma Today

August 19 2019 - Is Pfizer’s established drugs’ decline in China a canary in a coalmine?
Is Pfizer’s established drugs’ decline in China a canary in a coalmine?
Amgen biosimilar debut boosted by UnitedHealthcare coverage
Novartis CEO says FDA process could’ve been handled better
Translating microbiome research into treatments
*scroll through previous pages at the bottom to get older news*

Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe

Today's most popular searches:

Current News

submit a press release

Click here to stay updated on CP happenings
Is Pfizer's established drugs' decline in China the ‘canary in the coalmine?’
Fierce Pharma
Monday, August 19, 2019 - 11:55am
tags:
Pfizer, Upjohn, China
Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Biopharma Dive
Monday, August 19, 2019 - 11:52am
tags:
insurers, Amgen, biosimilars, Avastin, Herceptin, Roche, UnitedHealthcare
Juvenescence raises $100M to fund longevity assets to early readouts
Fierce Biotech
Monday, August 19, 2019 - 10:56am
tags:
Juvenescence, anti-aging, longevity, clinical trials
Zepsyre has a path to market at last
EP Vantage
Monday, August 19, 2019 - 10:55am
tags:
PharmaMar, FDA, Zepsyre, small cell lung cancer
Solid Biosciences Surges on DMD Gene Therapy Study Amendments
Yahoo/Zacks.com
Monday, August 19, 2019 - 10:54am
tags:
Solid Biosciences, SGT-001, Duchenne Muscular Dystrophy
This troubled biotech needed cash, so it turned to a predatory lender: its own CEO
Stat
Monday, August 19, 2019 - 10:44am
tags:
Northwest Biotherapeutics
Translating microbiome research into treatments
Pharmaforum
Monday, August 19, 2019 - 10:43am
tags:
microbiome, drug development
Novartis CEO Says FDA Process Could Have Been Handled Better
Bloomberg
Monday, August 19, 2019 - 10:33am
tags:
Novartis, Pharma CEOs, Vas Narasimhan, Zolgensma
Many clinical trials for new cancer drugs didn’t include any data on race
Stat
Monday, August 19, 2019 - 10:30am
tags:
clinical trials, race, cancer, racial diversity
Sarepta's Lone Analyst Skeptic Takes On 22 Bulls With Renewed Warnings
Bloomberg
Monday, August 19, 2019 - 10:28am
tags:
Sarepta Therapeutics, analysts, Duchenne Muscular Dystrophy, Vyondys 53, Exondys 51
AI may not be able to keep up with real-world medicine use, experts warn
Pharmaforum
Monday, August 19, 2019 - 10:26am
tags:
artificial intelligence, digital health
Novartis to answer U.S. Senate demand for data manipulation details
Yahoo/Reuters
Monday, August 19, 2019 - 9:55am
tags:
Novartis, Senate, Zolgensma
What happened a year ago this week in biopharma? August 12-18, 2018
CP WIre
Sunday, August 18, 2019 - 4:30pm
tags:
Regeneron, Novartis, wet-AMD, Eylea, ethics, Vertex Pharmaceuticals, Kalydeco, cystic fibrosis, Bristol-Myers Squibb, Opdivo, Merck, Keytruda, SCLC
How Big Is Celgene's Latest Good News?
Motley Fool
Sunday, August 18, 2019 - 12:38pm
tags:
Celgene, Otezla, Revlimid, Inrebic
The Week Ahead In Biotech: FDA Goes Into Overdrive In A Quiet Week
Yahoo/Benzinga
Sunday, August 18, 2019 - 12:29pm
tags:
Nabriva, Sarepta Therapeutics, TrovaGene, Medtronic
FDA Approval 'Finally' Recognizes Vertebral Body Tethering as a Mainstream Scoliosis Treatment
Medical Devices and Diagnostics Industry
Saturday, August 17, 2019 - 11:00pm
tags:
Zimmer Biomet, Scoliosis, FDA, vertebral body tethering, devices
Biopharma's biggest sellers – the oldies that just keep giving
Evaluate Pharma
Saturday, August 17, 2019 - 1:38pm
tags:
Amgen, Enbrel, patents, biologics, Advair, Zantac, Liptor, Plavix
Alder BioPharmaceuticals approaches rare status for a Seattle biotech
Bizjournals
Saturday, August 17, 2019 - 1:33pm
tags:
Alder Biopharmaceuticals, Seattle, migraines
How Merck Could Ride 'The Keytruda Wave' To Dominate These Rivals
Investors Business Daily
Saturday, August 17, 2019 - 1:31pm
tags:
Merck, Keytruda, cancer
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
Xconomy
Saturday, August 17, 2019 - 1:28pm
tags:
IPOs, SpringWorks Therapeutics, Pfizer, Satsuma Pharmaceuticals

Pages

Latest CP Wire Articles

What happened a year ago this week in biopharma? August 12-18, 2018
Physician-Rep Conversation - A Lesson From Cafepharma
Monopar Therapeutics Files for $40 Million IPO
Smile Direct Club Files for $100 Million IPO
89Bio starting Proof of Concept Trial for NASH therapy and announcing expansion of leadership team
Silk Road Medical Files for $159 Million Offering
Vida Ventures Raises $600 Million for New Life Science Fund
Vapotherm Files for $57 Million Offering
Device reps in the OR - one rep's comments
Reckitt Benckiser Group PLC agrees to pay $1.4 billion to settle whistleblower cases

Latest Pharmagather Articles

Test 3 HCL
pharmexec deals
Glyphosate analysis in wine using SPE
pharmexec deals
Characterization of a Novel Antibody Drug Conjugate Mimic by SEC and HIC
pharmexec deals
Agilent QuickProbe Technology
pharmexec deals
Test 3 HCL
pharmexec european news
Glyphosate analysis in wine using SPE
pharmexec european news
Characterization of a Novel Antibody Drug Conjugate Mimic by SEC and HIC
pharmexec european news
Agilent QuickProbe Technology
pharmexec european news
Test 3 HCL
pharmexec marketing
Pharma Jobs from Indeed


Pharma and Device News from NASDAQ

Progressive Care Inc. Files an Amended June 30, 2019 Quarterly Report
Thursday, August 15, 2019 - 5:11pm
Fibrocell Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
Wednesday, August 14, 2019 - 4:45pm
Misonix Reports Fourth Quarter and Fiscal Year 2019 Results
Wednesday, August 14, 2019 - 4:05pm
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2019
Wednesday, August 14, 2019 - 4:05pm
Macrogol/Polyethylene Glycol (PEG) Market To Reach USD 4,934.6 Million By 2026 | Reports And Data
Wednesday, August 14, 2019 - 11:28am
ReNetX Bio Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of Fusion Protein AXER-204
Wednesday, August 14, 2019 - 9:02am
Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results
Wednesday, August 14, 2019 - 7:30am
CytoDyn Provides Update on Dose Escalating Trial with Leronlimab for HIV Monotherapy for a Potential Pivotal Trial
Wednesday, August 14, 2019 - 6:00am
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
Tuesday, August 13, 2019 - 5:48pm
Endonovo Therapeutics Announces Second Quarter Results
Tuesday, August 13, 2019 - 1:39pm

Want to host your own webinar?

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.